Hematology

A breakthrough study has reported encouraging outcomes using autologous chimeric antigen receptor T cells in patients with relapsed or refractory T-cell acute lymphoblastic leukaemia.

A recent multicenter study led by researchers including Talha Badar and Moazzam Shahzad has highlighted the challenging prognosis of TP53-mutated acute myeloid leukemia.

Low levels of FOXP3+ regulatory T cells are associated with worse progression-free survival and more aggressive disease characteristics in patients with angioimmunoblastic T cell lymphoma.

A new study has highlighted the optimal treatment strategies for managing non-Hodgkin lymphoma in patients with Sjögren’s disease

A new study has revealed insights into the behaviour of platelet factor XIII-A, a major cytoplasmic protein, during platelet activation.

Researchers have made a significant discovery that could one day help tailor immunotherapy treatments for patients with multiple myeloma.

Older adults diagnosed with hematologic malignant neoplasms experience cognitive decline at a rate similar to normal aging.

The ASC4FIRST trial highlights asciminib, a new BCR::ABL1 inhibitor, as a potential alternative to current tyrosine kinase inhibitors for chronic myeloid leukaemia